$IMLFF SEATTLE, WA--(Marketwired - Feb 15, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, today announced the publication of an article and video CEO interview covering InMed Pharmaceuticals Inc.'s ( OTCQB : IMLFF ) ( CSE : IN.CN ) groundbreaking cannabinoid biosynthesis technology.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.